Current controlled trials in cardiovascular medicine / / BioMed Central, PubMed Central.
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | London : : BioMed Central,, [2000] |
Publication history: | Vol. 1, no. 1 (2000)-6:18 (Dec. 13, 2005). |
Language: | English |
Physical Description: | 1 online resource |
Notes: |
|
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993573745204498 |
---|---|
lccn |
2002252924 |
ctrlnum |
(DE-599)ZDB2040523-6 (OCoLC)48407034 (CKB)111018467304014 (CONSER)--2002252924 (NjHacI)99111018467304014 (EXLCZ)99111018467304014 |
collection |
bib_alma |
record_format |
marc |
spelling |
Current controlled trials in cardiovascular medicine (Online) CURR CONTROL TRIALS CARDIOVASC MED Curr control trials cardiovasc med Curr. control. trials, Cardiovasc. med. (Online) Current controlled trials. Cardiovascular medicine (Online) Current controlled trials in cardiovascular medicine / BioMed Central, PubMed Central. CCTCVM [London] : BioMed Central, 2000-2005. London : BioMed Central, [2000] 1 online resource Annual text txt rdacontent computer c rdamedia online resource cr rdacarrier Vol. 1, no. 1 (2000)-6:18 (Dec. 13, 2005). Refereed/Peer-reviewed Unrestricted online access star Title from contents screen (viewed July 2, 2002). Chemical abstracts 0009-2258 Vol. 1 complete in three issues. Latest issue consulted: Vol. 2, no. 6 (2001). Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins -- Comments on ALLHAT and doxazosin -- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? -- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight -- Debate: PCI vs CABG: a moving target, but we are gaining -- Debate: Should statin be used in patients with heart failure? -- Debate: Statins should be used in patients with heart failure -- Cytokines as new treatment targets in chronic heart failure -- Therapeutic angiogenesis for cardiovascular disease -- Distal protection devices during percutaneous coronary and carotid interventions -- Biventricular pacing in heart failure: update on results from clinical trials -- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) -- A new era in hypertension research: discussing the findings of ALLHAT. Cardiology Periodicals. Clinical trials Periodicals. Cardiology. fast (OCoLC)fst00847121 Clinical trials. fast (OCoLC)fst00864429 Cardiovascular Diseases therapy. Cardiovascular Diseases physiopathology. Cardiovascular Diseases Periodicals. Controlled Clinical Trial. Periodicals. fast (OCoLC)fst01411641 TRIALS (CKB)1000000000026276 (DLC)2006243052 1468-6708 National Institutes of Health (U.S.). PubMed Central. |
language |
English |
format |
Journal |
author2 |
National Institutes of Health (U.S.). PubMed Central. |
author_facet |
National Institutes of Health (U.S.). PubMed Central. National Institutes of Health (U.S.). PubMed Central. |
author2_role |
TeilnehmendeR |
author_corporate |
National Institutes of Health (U.S.). PubMed Central. |
title |
Current controlled trials in cardiovascular medicine / |
spellingShingle |
Current controlled trials in cardiovascular medicine / Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins -- Comments on ALLHAT and doxazosin -- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? -- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight -- Debate: PCI vs CABG: a moving target, but we are gaining -- Debate: Should statin be used in patients with heart failure? -- Debate: Statins should be used in patients with heart failure -- Cytokines as new treatment targets in chronic heart failure -- Therapeutic angiogenesis for cardiovascular disease -- Distal protection devices during percutaneous coronary and carotid interventions -- Biventricular pacing in heart failure: update on results from clinical trials -- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) -- A new era in hypertension research: discussing the findings of ALLHAT. |
title_short |
CURR CONTROL TRIALS CARDIOVASC MED |
title_full |
Current controlled trials in cardiovascular medicine / BioMed Central, PubMed Central. |
title_fullStr |
Current controlled trials in cardiovascular medicine / BioMed Central, PubMed Central. |
title_full_unstemmed |
Current controlled trials in cardiovascular medicine / BioMed Central, PubMed Central. |
title_auth |
Current controlled trials in cardiovascular medicine / |
title_alt |
Current controlled trials in cardiovascular medicine (Online) |
title_new |
Current controlled trials in cardiovascular medicine / |
title_sort |
current controlled trials in cardiovascular medicine / |
publisher |
BioMed Central, |
publishDate |
2000 |
physical |
1 online resource |
dateSpan |
Vol. 1, no. 1 (2000)-6:18 (Dec. 13, 2005). |
contents |
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins -- Comments on ALLHAT and doxazosin -- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? -- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight -- Debate: PCI vs CABG: a moving target, but we are gaining -- Debate: Should statin be used in patients with heart failure? -- Debate: Statins should be used in patients with heart failure -- Cytokines as new treatment targets in chronic heart failure -- Therapeutic angiogenesis for cardiovascular disease -- Distal protection devices during percutaneous coronary and carotid interventions -- Biventricular pacing in heart failure: update on results from clinical trials -- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) -- A new era in hypertension research: discussing the findings of ALLHAT. |
issn |
1468-6694 1468-6708 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC681 |
callnumber-sort |
RC 3681 A1 C877 42001 |
genre |
Periodicals. Controlled Clinical Trial. Periodicals. fast (OCoLC)fst01411641 |
genre_facet |
Periodicals. Controlled Clinical Trial. |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616 |
dewey-sort |
3616 |
dewey-raw |
616 |
dewey-search |
616 |
oclc_num |
48407034 |
work_keys_str_mv |
UT currentcontrolledtrialsincardiovascularmedicineonline AT nationalinstitutesofhealthuspubmedcentral currentcontrolledtrialsincardiovascularmedicine AT nationalinstitutesofhealthuspubmedcentral cctcvm |
status_str |
n |
ids_txt_mv |
(DE-599)ZDB2040523-6 (OCoLC)48407034 (CKB)111018467304014 (CONSER)--2002252924 (NjHacI)99111018467304014 (EXLCZ)99111018467304014 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Current controlled trials in cardiovascular medicine / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796652595106807808 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nas-a2200565-a-4500</leader><controlfield tag="001">993573745204498</controlfield><controlfield tag="005">20240112213020.0</controlfield><controlfield tag="006">m-----o--d--------</controlfield><controlfield tag="007">cr-cnu||||||||</controlfield><controlfield tag="008">011112d20002005enkuu-pso-----0----0eng-c</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2002252924</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBB0E1444</subfield><subfield code="2">bnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">2040523-6</subfield><subfield code="2">DE-600</subfield></datafield><datafield tag="022" ind1=" " ind2=" "><subfield code="a">1468-6694</subfield></datafield><datafield tag="030" ind1=" " ind2=" "><subfield code="a">CCTCD6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)ZDB2040523-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)48407034</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)111018467304014</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CONSER)--2002252924</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)99111018467304014</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)99111018467304014</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC681.A1</subfield><subfield code="b">.C877 2001</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616</subfield><subfield code="2">23</subfield></datafield><datafield tag="130" ind1="0" ind2=" "><subfield code="a">Current controlled trials in cardiovascular medicine (Online)</subfield></datafield><datafield tag="210" ind1=" " ind2=" "><subfield code="a">CURR CONTROL TRIALS CARDIOVASC MED</subfield></datafield><datafield tag="210" ind1="0" ind2="0"><subfield code="a">Curr control trials cardiovasc med</subfield></datafield><datafield tag="210" ind1="0" ind2=" "><subfield code="a">Curr. control. trials, Cardiovasc. med.</subfield><subfield code="b">(Online)</subfield></datafield><datafield tag="222" ind1=" " ind2="0"><subfield code="a">Current controlled trials. Cardiovascular medicine</subfield><subfield code="b">(Online)</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Current controlled trials in cardiovascular medicine /</subfield><subfield code="c">BioMed Central, PubMed Central.</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">CCTCVM</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">[London] :</subfield><subfield code="b">BioMed Central,</subfield><subfield code="c">2000-2005.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">BioMed Central,</subfield><subfield code="c">[2000]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="310" ind1=" " ind2=" "><subfield code="a">Annual</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="362" ind1="0" ind2=" "><subfield code="a">Vol. 1, no. 1 (2000)-6:18 (Dec. 13, 2005).</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Refereed/Peer-reviewed</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from contents screen (viewed July 2, 2002).</subfield></datafield><datafield tag="510" ind1="0" ind2=" "><subfield code="a">Chemical abstracts</subfield><subfield code="x">0009-2258</subfield></datafield><datafield tag="515" ind1=" " ind2=" "><subfield code="a">Vol. 1 complete in three issues.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Latest issue consulted: Vol. 2, no. 6 (2001).</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins -- Comments on ALLHAT and doxazosin -- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? -- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight -- Debate: PCI vs CABG: a moving target, but we are gaining -- Debate: Should statin be used in patients with heart failure? -- Debate: Statins should be used in patients with heart failure -- Cytokines as new treatment targets in chronic heart failure -- Therapeutic angiogenesis for cardiovascular disease -- Distal protection devices during percutaneous coronary and carotid interventions -- Biventricular pacing in heart failure: update on results from clinical trials -- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) -- A new era in hypertension research: discussing the findings of ALLHAT.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cardiology</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Clinical trials</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiology.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst00847121</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst00864429</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">therapy.</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">physiopathology.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cardiovascular Diseases</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Periodicals.</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Controlled Clinical Trial.</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Periodicals.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01411641</subfield></datafield><datafield tag="785" ind1="0" ind2="0"><subfield code="t">TRIALS</subfield><subfield code="w">(CKB)1000000000026276</subfield><subfield code="w">(DLC)2006243052</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="x">1468-6708</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Institutes of Health (U.S.).</subfield><subfield code="b">PubMed Central.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">JOURNAL</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-02-25 02:47:25 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2012-02-25 23:26:25 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAJ Directory of Open Access Journals</subfield><subfield code="P">DOAJ Directory of Open Access Journals</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5341823350004498&Force_direct=true</subfield><subfield code="Z">5341823350004498</subfield><subfield code="m"> Available from 2000 until 2013.</subfield><subfield code="b">Available</subfield><subfield code="8">5341823350004498</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="Z">5341823350004498</subfield><subfield code="A">2000</subfield><subfield code="B">2013</subfield></datafield></record></collection> |